NCT04202562

Brief Summary

The Kahook Dual Blade is a single-use device specially designed to create a clean cut in the trabecular meshwork. This ablation in the trabecular meshwork allows a better outflow of the aqueous humor, thus reducing the intraocular pressure (IOP), theoretically beyond the IOP reduction achieved by other minimally invasive glaucoma surgery (MIGS) devices. Studies already published showed good results in terms of the reduction of the number of glaucoma medications and the reduction in the IOP, but not a single study has been performed prospectively comparing the efficacy of the technique, not even with the cataract surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

December 15, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 17, 2019

Completed
Last Updated

December 20, 2019

Status Verified

December 1, 2019

Enrollment Period

10 months

First QC Date

December 15, 2019

Last Update Submit

December 17, 2019

Conditions

Keywords

GlaucomaOcular hypertensionGlaucoma, Open-AngleAb interno trabeculectomyPhacoemulsificationCombined surgeryMinimally Invasive Glaucoma Surgery

Outcome Measures

Primary Outcomes (2)

  • Evolution during follow up of the intraocular pressure

    in mmHg

    Up to 12 months

  • Reduction in number of glaucoma medications

    Difference between number of glaucoma medications before and after the treatment

    Up to 12 months

Secondary Outcomes (5)

  • Increase in visual acuity

    Up to 12 months

  • Rate of reduction in endothelial cell count

    Up to 12 months

  • Increase of corneal astigmatism

    Up to 12 months

  • Rate of visual field progression

    Up to 12 months

  • Proportion of patients achieving the success endpoint

    Up to 12 months

Study Arms (2)

Combined surgery

EXPERIMENTAL

Participants intervened of combined ab interno trabeculectomy and cataract surgery at the same time

Procedure: Ab interno trabeculectomyProcedure: Cataract

Cataract surgery

ACTIVE COMPARATOR

Participants intervened of cataract surgery alone

Procedure: Cataract

Interventions

Ab interno trabeculectomy performed after pupil contraction and 90 degrees ablation of the nasal trabecular meshwork

Combined surgery
CataractPROCEDURE

Cataract surgery with minimal clear cornea incision and phacoemulsification

Cataract surgeryCombined surgery

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants aged 18 - 85 years
  • Full comprehension and signing of the informed consent
  • Preoperative intraocular pressure below 24 mmHg and at least one glaucoma medication
  • Previous diagnose of open-angle glaucoma or ocular hypertension, including pseudoexfoliative glaucoma or pigment dispersion syndrome
  • Mild to moderate glaucoma, according to the Hodapp-Parrish-Anderson classification

You may not qualify if:

  • Not signing of the informed consent
  • Not being able to attend to all the follow-up visits
  • Young females during pregnancy or lactation
  • Any other form of glaucoma not previously mentioned
  • Glaucoma secondary to elevated episcleral venous pressure
  • Preoperative best-corrected visual acuity lower than 0.1
  • Clear lens extraction
  • Severe or end-stage glaucoma
  • Previous glaucoma surgery, cataract surgery or retinal surgery
  • Patients taking anticoagulant medication that could not be discontinued during the perioperative period
  • Oral anhydrase carbonic inhibitors
  • Severe or uncontrolled systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital San Carlos

Madrid, 28040, Spain

Location

Related Publications (3)

  • Greenwood MD, Seibold LK, Radcliffe NM, Dorairaj SK, Aref AA, Roman JJ, Lazcano-Gomez GS, Darlington JK, Abdullah S, Jasek MC, Bahjri KA, Berdahl JP. Goniotomy with a single-use dual blade: Short-term results. J Cataract Refract Surg. 2017 Sep;43(9):1197-1201. doi: 10.1016/j.jcrs.2017.06.046.

    PMID: 28991617BACKGROUND
  • Dorairaj SK, Seibold LK, Radcliffe NM, Aref AA, Jimenez-Roman J, Lazcano-Gomez GS, Darlington JK, Mansouri K, Berdahl JP. 12-Month Outcomes of Goniotomy Performed Using the Kahook Dual Blade Combined with Cataract Surgery in Eyes with Medically Treated Glaucoma. Adv Ther. 2018 Sep;35(9):1460-1469. doi: 10.1007/s12325-018-0755-4. Epub 2018 Aug 4.

    PMID: 30078175BACKGROUND
  • Ventura-Abreu N, Garcia-Feijoo J, Pazos M, Biarnes M, Morales-Fernandez L, Martinez-de-la-Casa JM. Twelve-month results of ab interno trabeculectomy with Kahook Dual Blade: an interventional, randomized, controlled clinical study. Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2771-2781. doi: 10.1007/s00417-021-05213-0. Epub 2021 Apr 27.

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionEye DiseasesHypertensionCataractGlaucoma

Interventions

Cataract Extraction

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesLens Diseases

Intervention Hierarchy (Ancestors)

Refractive Surgical ProceduresOphthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Julian Garcia Feijoo, Professor

    Hospital San Carlos

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One group received combined surgery, while the other cataract surgery alone
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 15, 2019

First Posted

December 17, 2019

Study Start

February 2, 2017

Primary Completion

November 29, 2017

Study Completion

November 30, 2018

Last Updated

December 20, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Individual participant data will only be shared if other investigators in their respective centers perform the clinical trial in a similar fashion. Personal information will not ever be shared, and medical records would be shared according to the current legislation of the European Union

Locations